V3003

モノクローナル抗血管内皮増殖因子受容体2(KDR)抗体 マウス宿主抗体

clone 260.4, KDR-2, ascites fluid

• 別名: モノクロナール抗血管内皮細胞増殖因子受容体2 マウス宿主抗体, 抗KDR抗体, 抗VEGFR-2抗体
• NACRES: NA.41
• UNSPSC Code: 51111800
• Conjugate: unconjugated
• Clone: 260.4, KDR-2, monoclonal
• Application: ELISA (i), IHC (f), WB
• Citations: 13

特性

• biological source: mouse
• Quality Level: 200
• conjugate: unconjugated
• antibody form: ascites fluid
• antibody product type: primary antibodies
• clone: 260.4, KDR-2, monoclonal
• contains: 15 mM sodium azide
• species reactivity: human
• technique(s): immunohistochemistry (frozen sections): suitable, indirect ELISA: suitable, western blot: 1:500 using insect cell culture supernatant expressing human extracellular recombinant VEGFR or VEGF Receptor-2 (KDR, FLK-1)/FC Chimera human, recombinant
• isotype: IgG1

詳細

General description

KDRレセプタ-(VEGFRa)は造血幹細胞(HSC)のマ-カ-とされており、多能性のHSCと、系譜が約束されたHSC前駆体とは区別されます。

Monoclonal Anti-Vascular Endothelial Growth Factor Receptor-2 (mouse IgG1 isotype) is derived from the KDR-2 hybridoma produced by the fusion of mouse myeloma cells and splenocytes from an immunized mouse. Vascular endothelial growth factor receptor 2 (VEGFR2) is a type V receptor tyrosine kinase, also known as kinase insert domain receptor (KDR) or fetal liver kinase 1 (Flk-1). It a glycosylated protein with an immunoglobulin (Ig)-like domains, a transmembrane domain and a tyrosine kinase domain. The KDR gene is mapped to human chromosome 4q12 and is widely expressed in all vessel-derived endothelial cells and hematopoietic stem cells.

Immunogen

精製リコンビナントヒト細胞外VEGFレセプタ-2(KDR)。

Application

Monoclonal Anti-Vascular Endothelial Growth Factor Receptor-2 (KDR) antibody produced in mouse has been used in:

• immunofluorescence[1]
• immunohistochemistry[1]
• immunoblotting[1]
• enzyme-linked immunosorbent assay(ELISA)

Biochem/physiol Actions

ヒトVEGFレセプタ-2と特異的に反応します。こののクロ-ン番号は260.4とも表記されます。Flt1(VEGFR-1)、Flt4(VEGFR-3)、血小板由来増殖因子レセプタ-(PDGF-R)は認識しません。

Vascular Endothelial Growth Factor Receptor-2 (VEGF R2) have high affinity for vascular endothelial growth factor-A (VEGF-A), hence facilitates most of the endothelial growth and survival signals from VEGF-A. It also plays a pivotal role in vascular development, vascular permeability, embryonic hematopoiesis and regulation of angiogenesis.

Vascular endothelial growth factor receptor 2 (VEGFR2) or kinase insert domain receptor (KDR) is a VEGF receptor, which stimulates its mitogenic activity. It is crucial for vascular endothelial cell development. VEGFR2 expression is elevated in invasive breast cancer, hemangiomas and angiosarcomas. KDR expressing cells show striking changes in cell morphology, actin reorganization and membrane ruffling, chemotaxis, and mitogenicity in response to VEGF. Antibodies that react specifically with the VEGF receptor are useful for the study of the specific differential tissue expression and intracellular localization of the receptor in normal and neoplastic tissue.

Physical form

The product is provided as ascites fluid with 15 mM sodium azide as a preservative.

Preparation Note

For continuous use, store at 2-8 °C for up to one month. For extended storage freeze in working aliquots. Repeated freezing and thawing, or storage in "frost-free" freezers,is not recommended. If slight turbidity occurs upon prolonged storage, clarify the solution by centrifugation before use.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

安全性情報

• 保管分類: 10 - Combustible liquids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable